Mendelian randomization confirmed a significant causal relationship between elevated RALB expression and increased risk of breast hypertrophy (odds ratio = 1.26; 95% confidence interval: 1.17–1.35; P <  .001). The gene discussed is RALB; the disease is Breast hypertrophy.